Relationship between induced sputum cytology and inflammatory status with lung structural and functional abnormalities in asbestosis

American Journal of Industrial Medicine

Volumn 51, Issue 3, 2008, Pages 186-194

  Setta, Josè Henrique ^a,b,f   Neder, José Alberto ^a,g   Bagatin, Ericson ^b,c,f   Terra Filho, Mario ^d,h   Nápolis, Lara Maris ^a   Dal Corso, Simone ^a,e,i   Amorin, Maria Marta Ferreira ^a   Rodrigues, Reynaldo Tavares ^a,j   Fernandes, Ana Luísa Godoy ^a   Nery, Luiz Eduardo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Jundiai Medical School   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSIDADE NOVE DE JULHO   (Brazil)

^f Federal University of São Paulo ^*  (Brazil)

^g Respiratory Division

^h Pulmonary Division   (United States)

ⁱ Rehabilitation Division

^j Diagnostic Imaging Department

more..

Author keywords

Asbestosis; Cytokines; Induced sputum; Inflammation; Pulmonary function

Indexed keywords

INTERLEUKIN 8;

ADULT; AGED; ARTICLE; ASBESTOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FUNCTIONAL STATUS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFLAMMATION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG STRUCTURE; MALE; SPUTUM CYTODIAGNOSIS; TOTAL LUNG CAPACITY;

AGED; AGED, 80 AND OVER; ASBESTOSIS; BRAZIL; CASE-CONTROL STUDIES; HUMANS; INTERLEUKIN-8; INTERVIEWS AS TOPIC; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; SPIROMETRY; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 39549120649     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.20546     Document Type: Article

References (41)

1. American Thoracic Society Documents. 2004. Diagnosis and initial management of nonmalignant disease related to asbestos. Am J Respir Crit Care Med 170:691-715.
2. ATS/ERS Task Force. 2005. Standardization of lung function testing. Standardization of the measurement of spirometry. Eur Respir J 26:319-338.
3. Bagatin E, Neder JA, Nery LE, Terra-Filho M, Kavakama JI, Castelo A, Capelozzi V, Sette A, Kitamura S, Favero M, Moreira-Filho DC, Tavares R, Peres C, Becklake MR. 2005. Non-malignant consequences of decreasing asbestos exposure in the Brazil chrysotile mines and mills. J Occup Environ Med 62:381-389.
4. Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 153:4159-4168.
5. Broser M, Zhang Y, Aston C, Harkin T, Rom WN. 1996. Elevated interleukin-8 in the alveolitis of individuals with asbestos exposure. Int Arch Occup Environ Health 68:114-119.
6. Consensus Report. 1997. Asbestos, asbestosis and cancer: The Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 23:311-316.
7. Crapo RO, Gardner RM, 1992. Single breath carbon monoxide diffusing capacity (transfer factor): Recommendations for a standard technique. Am Rev Respir Dis 163:1299-1303.
8. Cullen MR, Merrill WW. 1992. Association between neutrophil concentration in bronchoalveolar lavage fluid and recent losses in diffusing capacity in men formerly exposed to asbestos. Chest 102:682-687.
9. D'Ippolito R, Foresi A, Chetta A, Casalini A, Castagnaro A, Leoni C, Olivieri D. 1999. Induced sputum in patients with newly diagnosed sarcoidosis. Chest 115:1611-1615.
10. Fahy JV, Wong H, Liu j, Boushey HA. 1995. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am J Respir Crit Care Med 152:53-58.
11. Fireman E. 2001. Induced sputum: Opening a new window to the lung. Sarc Vasc Diff Lung Dis 18:263-271.
12. Fireman E, Greif J, Schwarz Y, Man A, Ganor E, Ribak Y, Lerman Y. 1999a. Assessment of hazardous dust exposure by BAL and induced sputum. Chest 115:1720-1728.
13. Fireman E, Topilsky I, Greif J, Lerman Y, Schwarz Y, Man A, Topilsky M. 1999b. Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease. Respir Med 93:827-834.
14. Gamsu G, Salmon CJ, Warnock ML, Blanc PD. 1995. CT quantification of interstitial fibrosis in patients with asbestosis: A comparison of two methods. Am J Roentgenol 164:63-68.
15. Harkin TJ, McGuinness G, Goldring R, Goldring R, Cohen H, Parker JE, Crane M, Naidich DP, Rom WN. 1996. Differentiation of the ILO boundary chest Roentgenograph (0/1 to 1/0) in asbestosis by high resolution computed tomography scan, alveolitis and respiratory impairment. J Occup Envirom Med 38:46-52.
16. International Labour Office. 2000. Guideliness for use of ILO international classification of radiographs of pneumoconiosis. Geneva, Switzerland: International Labour Office.
17. Lerman Y, Schwarz Y, Kauffman G, Ganor E, Fireman E. 2003. Case series: Use of induced sputum in the evaluation of occupational lung diseases. Arch Environ Health 58:284-289.
18. Maestrelli P, Saetta M, Di Stefano A, Calcagni PG, Turato G, Ruggieri MP, Roggeri A, Mapp CE, Fabbri LM. 1995. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 152:1926-1931.
19. Mossman BT, Churg A. 1998. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 157:1666-1680.
20. Medical Research Council's Committee on Research into Chronic Bronchitis. 1966. Questionnaire on respiratory symptoms. London: Medical Research Council.
21. Mukaida N. 2003. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 284:L566-L577.
22. Nápolis LM, Sette AA, Bagatin E, Terra-Filho M, Rodrigues RT, Kavakama JI, Neder JA, Nery LE. 2004. Chronic dyspnea and altered respiratory function in former workers with asbestosis evaluated to determine benefits. J Pneumol 30:528-534.
23. Neder JA, Andreoni S, Castelo-Filho A, Nery LE. 1999a. Reference values for lung function tests. I. Static volumes. Braz J Med Biol Respir 32:703-717.
24. Neder JA, Andreoni S, Peres C, Nery LE. 1999b. Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Respir 32:729-737.
25. Neri S, Boraschi P, Antonelli A, Falaschi F, Baschieri L. 1996. Pulmonary function, smoking habits, and high-resolution computed tomography (HRCT) early abnormalities of lung and pleural fibrosis in shipyard workers exposed to asbestos. Am J Ind Med 30:588-595.
26. Pereira CA, Barreto SP, Simões JG, Pereira FW, Gerstler JG, Nakatami J. 1992. Valores de referência para espirometria em uma amostra da população brasileira adulta. J Pneumol 18:10-22.
27. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J. 1992. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47:25-29.
28. Pizzichini E, Pizzichini MMM, Efthiamidis A, Hargreave FE, Dolovich J. 1996. Measurement of inflammatory indices in induced sputum: Effects of selection of sputum to minimize salivary contamination. Eur Respir J 9:1174-1180.
29. Robledo R, Mossman BT. 1999. Cellular and molecular mechanisms of asbestos-induced fibrosis. J Cell Physiol 180:158-166.
30. Rom WN, Bitterman PB, Rennard SI, Cantin A, Crystal RG. 1987. Characterization of the lower respiratory tract inflammation of nonsmoking individuals with Interstitial Lung Disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis 136:1429-1434.
31. Rosenthal GJ, Germolec DR, Blazca ME, Corsini E, Simeonova P, Pllock P, Kong LY, Kwon J, Luster MI. 1994. Asbestos stimulates IL-8 production from human lung epithelial cells. J Immunol 153:3237-3244.
32. Schwartz DA, Galvin JR, Frees KL, Dayton CS, Burmeister LF, Merchant JA, Hunninghake GW. 1993. Clinical relevance of cellular mediators of inflammation in workers exposed to asbestos. Am Rev Respir Dis 148:68-74.
33. Sette A, Neder JA, Nery LA, Kawakama J, Rodrigues RT, Terra-Filho M, Guimarães S, Bagatin E, Müller N. 2004. Thin-section CT abnormalities and pulmonary gas exchange impairment in workers exposed to asbestos. Radiology 232:66-74.
34. Sibille Y, Reynolds HY 1989. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141:471-501.
35. Spurzem JR, Saltini C, Rom W, Winchester J, Crystal RG. 1987. Mechanisms of macrophage accumulation in the lungs of asbestos-exposed subjects. Am Rev Respir Dis 136:276-280.
36. Sulotto F, Capallaro E, Chiesa A, Villari S, Bontempi S, Sulotto F, Scansetti G. 1997. Relationship between asbestos bodies in sputum and the number of specimens. Scand J Work Environ Health 23:48-53.
37. Teschler H, Thompson AB, Dollenkamp R, Konietzko N, Costabel U. 1996. Relevance of asbestos bodies in sputum. Eur Respir J 9:680-686.
38. Thomas RA, Green RH, Brightling CE, Birring SS, Parker D, Hons BSC, Wardlaw AJ, Pavord ID. 2004. The influence of age on induced sputum counts in normal subjects. Chest 126:1811-1814.
39. Tsiligianni I, Tzanakis N, Kyriakou D, Chrysofakis G, Siafakas N, Bouros D. 2002. Comparison of sputum induction with bronchoalveolar lavage cell differential counts in patients with sarcoidosis. Vasc Diffuse Lung Dis 19:205-210.
40. Wang XR, Christiani DC. 2000. Respiratory symptoms and functional status in workers exposed to silica, asbestos, and coal mine dusts. J Occup Environ Med 42:1076-1084.
41. Xaubet A, Rodriguez-Roisin R, Bombí JÁ, Marin A, Roca J, Agustí-Vidal A. 1986. Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis. Am Rev Respir Dis 133:848-854.